Retracted: 5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage
Author
Longevity, Oxidative Medicine and Cellular
Source
Oxidative Medicine and Cellular Longevity
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-09-29
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
Oxidative Medicine and Cellular Longevity has retracted the article titled “5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage” [1].
After concerns were raised on PubPeer the article was found to contain duplicated images, where part of the second image (ALA-PDT-UVA) in Figure 1c is the same as the third image (ALA-PDT-UVA) in Figure 2a.
American Psychological Association (APA)
Longevity, Oxidative Medicine and Cellular. 2020. Retracted: 5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage. Oxidative Medicine and Cellular Longevity،Vol. 2020, no. 2020, pp.1-1.
https://search.emarefa.net/detail/BIM-1204044
Modern Language Association (MLA)
Longevity, Oxidative Medicine and Cellular. Retracted: 5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage. Oxidative Medicine and Cellular Longevity No. 2020 (2020), pp.1-1.
https://search.emarefa.net/detail/BIM-1204044
American Medical Association (AMA)
Longevity, Oxidative Medicine and Cellular. Retracted: 5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage. Oxidative Medicine and Cellular Longevity. 2020. Vol. 2020, no. 2020, pp.1-1.
https://search.emarefa.net/detail/BIM-1204044
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1204044
